课题基金 / 基金详情

Study of the molecular mechanism of synaptogenesis using withanolides, novel anti-dementia drugs

Study of the molecular mechanism of synaptogenesis using withanolides, novel anti-dementia drugs
新型抗痴呆药物茄内酯突触发生的分子机制研究
批准号:
17500249
负责人:
TOHDA Chihiro
金额:
$2.46万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

TOHDA Chihiro的其他基金

相似基金

相关文献

中文摘要
翻译
灌胃给予薇菜皂苷IV(10μ/kg/天),显著改善Aβ(25-35)注射(25nmol.i.c.v)引起的记忆障碍。并防止轴突、树突和突触的丢失。苦参苷IV可增强正常小鼠的物体再认记忆。在脊髓损伤的小鼠中,口服10μ/kg/d,连续21天,可改善小鼠的运动功能,增加轴突密度和周围神经系统髓鞘水平。梭米酮(1μM)可显著促进10μM Aβ(25-35)损伤的大鼠皮质神经元的轴突和树突再生以及突触重建。为了阐明索米酮的分子机制,我们在原代培养的神经元中鉴定了受体或相关分子,并用磷酸化抗体阵列将其磷酸化。小胶质细胞和神经元中的磷酸化RET水平增加。神经元内磷酸化AcK1水平升高。利用siRNA进行的基因敲除实验表明,RET和AcK1都参与了黏液的伸展。这些结果表明,RET和AcK1是神经元重建的关键分子。
英文摘要
Oral administration of withanoside IV (10 μmol/kg/day), an isolated compound from roots of Withania somnifera significantly improved memory deficits in Aβ(25-35)-injected (25 nmol, i.c.v.) mice and prevented loss of axons, dendrites, and synapses. The treatment with withanoside IV could enhance the object recognition memory in normal mice. In spinal cord injured mice, per oral treatment with withanoside IV (10 μmol/kg/day, for 21 days) improved locomotor functions in mice, and increased axonal density and the peripheral nervous system myelin level.Sominone, an aglycone of withanoside IV, was identified as the main metabolite after oral administration of withanoside IV. Sominone (1 μM) induced axonal and dendritic regeneration and synaptic reconstruction significantly in cultured rat cortical neurons damaged by 10 μM Aβ(25-35).To clarify the molecular mechanism of sominone, we identified receptors or associated molecules in primary cultured neurons, which were phosphorylated by sominone stimulation using phosphorylation antibody arrays. The level of phosphorylated RET increased in microglias and neurons. The level of phosphorylated ACK1 increased in neurons. Knockdown experiments using siRNA showed that both RET and ACK1 were involved in dedritic extension. These results suggest that roles of RET and ACK1 as key molecules for reconstruction of the neuronal
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of anti-neurodegenerative effects of Polygala tenuifolia in Aβ(23-35)-treated cortical neurons.
细叶远志对 Aβ(23-35) 处理的皮质神经元的抗神经退行性作用的表征。
DOI: --
发表时间: 2006
期刊: Biol.Pharm.Bull. 29
影响因子: --
作者: [Naito R., Tohda C.]
通讯作者: Tohda C.
Scientific basis for the anti-dementia drugs of constituents from Ashwagandha(Withania somnifera).
Ashwagandha(Withania somnifera)成分抗痴呆药物的科学依据。
DOI: --
发表时间: 2005
期刊: 和漢医薬学雑誌 22
影响因子: --
作者: [Tohda C., Komatsu K. and Kuboyama T.]
通讯作者: Komatsu K. and Kuboyama T.
Ginsengs Drugs-Molecular and chemical characteristics and possibility as antidementia drugs.
人参药物-分子和化学特性以及作为抗痴呆药物的可能性。
DOI: --
发表时间: 2005
期刊: Current topics in Nutraceutical Research 3
影响因子: --
作者: [Komatsu K., Tohda C. and Zhu S.]
通讯作者: Tohda C. and Zhu S.
Investigation of PI3Kknockout mice as an ADHD model
PI3K敲除小鼠作为 ADHD 模型的研究
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Nakanishi, R., Tohda, C., Yokozawa, T., Yamamoto, T., Kadowaki, M]
通讯作者: M
80
    Recovery from spinal cord injury in the chronic phase -the mechanism of denosomin, a novel compound with multiactivities-
    • 批准号:
      23500439
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      TOHDA Chihiro
    • 依托单位:
    海外基金